LEVOBUPIVACAINE ALTAN 0.625 mg/ml, solution for infusion 24 bags of 100 ml
Active ingredients: Levobupivacaine hydrochloride, Levobupivacaine
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for infusion24 bags of 100 mlpéridurale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LEVOBUPIVACAINE ALTAN 0,625 mg/mL, solution pour perfusion
- Pharmaceutical form
- solution pour perfusion
- Route of administration
- péridurale
- Presentation description
- 24 poches polypropylène souple suremballées/surpochées aluminium de 100 mL
- Marketing authorisation holder
- ALTAN PHARMACEUTICALS (ESPAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 12 Nov 2019
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60698225CIP75506026CIP133400955060260Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE LÉVOBUPIVACAÏNEsolution | — | SA |
| LÉVOBUPIVACAÏNEsolution | 0,625 mg · 1 mL de solution | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.